The AHSN National Polypharmacy Programme was launched in April 2022. The core principle of the programme is to support local systems to address problematic polypharmacy by using data to identify patients at potential risk of harm and support better conversations about medicines.

The programme is based on three core principles supported by a local community of practice to drive changes in practice:

  1. Population health management
    Using data (NHSBSA polypharmacy prescribing comparators) to understand population health risks and support prioritisation of patients for a structured medication review.
  2. Education and training
    Running local Polypharmacy Action Learning Sets (ALSs) to upskill the primary care workforce to be more confident about stopping unnecessary medicines.
  3. Public behaviour change
    The testing and evaluation of public-facing interventions to challenge and change public perceptions of prescribing and encourage patients to talk about medicines.

WE NEED YOU!

  • Prescribers (medical and non-medical) working in primary care with 12+ months experience to become accredited National AHSN Polypharmacy Action Learning Set Trainer.
  • Passionate geriatricians to share their experience as clinical champions.
  • To join our Polypharmacy – learning collaborative (community of practice): an open forum to share successes and challenges across the region and an opportunity to network with colleagues from all sectors.

To read more about this programme, visit the: AHSN’s polypharmacy webpage

To join your local community of practice, or find out how to get involved in the programme, please email: [email protected].

Latest Opportunities

Volunteering opportunities through Silverstone Park Schools Programme

Now entering its seventh year, the Silverstone Park Schools Programme inspires Year 8 and 9…

College of Life & Sports Sciences Careers Expo at Birmingham City University

Businesses are invited to attend Birmingham City University’s (BCU) College of Life & Sports Sciences…

The Life Sciences Innovative Manufacturing Fund

The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to…

Latest News

Veteran Medilink Midlands retirement announcement

Officially announced today (22 November), Medilink Midlands longest serving member of staff is set to…

Clinics will provide support to budding innovators

Budding entrepreneurs can get advice on how to bring their products to life thanks to…

World-class ‘accelerator’ to speed development of crucial rehabilitation technologies

A world-class impact accelerator will connect hundreds of East Midlands MedTech SMEs with health and…